SPHK1 and breast carcinoma: Sphingosine kinase 1 (SphK1), sphingosine-1-phosphate (S1P), and S1P receptors (S1PRs) expression have been suggested to be associated with progression to advanced tumor stages in estrogen (ER)-positive breast cancers in vivo [21].